1. Gong, Chuandong, Tu, Zewei, Long, Xiaoyan, Li, Jingying, Huang, Kai. 2023. Predictive role of E2F6 in cancer prognosis and responses of immunotherapy. In International immunopharmacology, 127, 111302. doi:10.1016/j.intimp.2023.111302. https://pubmed.ncbi.nlm.nih.gov/38071912/
2. Westendorp, Bart, Major, Jennifer L, Nader, Moni, Leenen, Frans H H, Tuana, Balwant S. 2012. The E2F6 repressor activates gene expression in myocardium resulting in dilated cardiomyopathy. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 26, 2569-79. doi:10.1096/fj.11-203174. https://pubmed.ncbi.nlm.nih.gov/22403008/
3. Pohlers, Michael, Truss, Matthias, Frede, Ute, Birchmeier, Carmen, Hagemeier, Christian. . A role for E2F6 in the restriction of male-germ-cell-specific gene expression. In Current biology : CB, 15, 1051-7. doi:. https://pubmed.ncbi.nlm.nih.gov/15936277/
4. Dahlet, Thomas, Truss, Matthias, Frede, Ute, Hagemeier, Christian, Weber, Michael. 2021. E2F6 initiates stable epigenetic silencing of germline genes during embryonic development. In Nature communications, 12, 3582. doi:10.1038/s41467-021-23596-w. https://pubmed.ncbi.nlm.nih.gov/34117224/
5. Major, Jennifer L, Salih, Maysoon, Tuana, Balwant S. 2017. E2F6 protein levels modulate drug induced apoptosis in cardiomyocytes. In Cellular signalling, 40, 230-238. doi:10.1016/j.cellsig.2017.09.022. https://pubmed.ncbi.nlm.nih.gov/28964969/
6. Jing, Tiantian, Wang, Boshi, Yang, Zhaojuan, Zhang, Li, Liu, Yongzhong. 2021. Deubiquitination of the repressor E2F6 by USP22 facilitates AKT activation and tumor growth in hepatocellular carcinoma. In Cancer letters, 518, 266-277. doi:10.1016/j.canlet.2021.07.044. https://pubmed.ncbi.nlm.nih.gov/34339800/
智鼠故事 
